Login to Your Account

Other News To Note

Friday, April 5, 2013
• Cyclacel Pharmaceuticals Inc., of Berkeley Heights, N.J., said it entered a definitive agreement with Summit, N.J.-based Celgene Corp. to sell four Cyclacel-owned patents related to the use of romidepsin injection for a one-time payment of $5.5 million.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription